Prevalence of use and interest in using glucagon-like peptide-1 receptor agonists for weight loss: a population study in Great Britain

Abstract Background This study aimed to assess the prevalence of glucagon-like peptide-1 (GLP-1) receptor agonist use and interest in using medications for weight loss among adults (≥ 18 years) in Great Britain. Methods Nationally representative household survey, January–March 2025 (n = 5893). Parti...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sarah E. Jackson, Jamie Brown, Clare Llewellyn, Oliver Mytton, Lion Shahab
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2026-01-01
coleção:	BMC Medicine
Assuntos:	Semaglutide Liraglutide Tirzepatide Ozempic Wegovy Saxenda
Acesso em linha:	https://doi.org/10.1186/s12916-025-04528-7
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!